amlodipine/valsartan novartis 5/80 amlodipine 5 mg/valsartan 80 mg film-coated tablet blister pack
novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.
apo-valsartan hctz 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack
apotex pty ltd - hydrochlorothiazide,valsartan -
apo-valsartan hctz 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack
apotex pty ltd - hydrochlorothiazide,valsartan -
apo-valsartan hctz 160/12.5 valsartan and hydrochlorothiazide 160/12.5 mg tablet blisters
apotex pty ltd - hydrochlorothiazide,valsartan -
apo-valsartan hctz 320/25 valsartan and hydrochlorothiazide 320/25 mg tablet blisters
apotex pty ltd - hydrochlorothiazide,valsartan -
apo-valsartan hctz 320/12.5 valsartan and hydrochlorothiazide 320/12.5 mg tablet blisters
apotex pty ltd - hydrochlorothiazide,valsartan -
amlodipine/valsartan/hct novartis 5/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 160 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).
amlodipino/valsartan/hidroclorotiazida mylan 10 mg/160 mg/12,5 mg comprimidos recubiertos con pelicula efg
mylan pharmaceuticals, s.l. - valsartan; amlodipino besilato; hidroclorotiazida - comprimido recubierto con pelÍcula - 160 mg/10 mg/12,5 mg - valsartan 160 mg; amlodipino besilato 10 mg; hidroclorotiazida 12,5 mg - valsartán, amlodipino e hidroclorotiazida
amlodipino/valsartan/hidroclorotiazida mylan 10 mg/160 mg/25 mg comprimidos recubiertos con pelicula efg
mylan pharmaceuticals, s.l. - valsartan; amlodipino besilato; hidroclorotiazida - comprimido recubierto con pelÍcula - 160 mg/10 mg/25 mg - valsartan 160 mg; amlodipino besilato 10 mg; hidroclorotiazida 25 mg - valsartán, amlodipino e hidroclorotiazida
amlodipino/valsartan/hidroclorotiazida mylan 10 mg/320 mg/25 mg comprimidos recubiertos con pelicula efg
mylan pharmaceuticals, s.l. - valsartan; amlodipino besilato; hidroclorotiazida - comprimido recubierto con pelÍcula - 320 mg/10 mg/25 mg - valsartan 320 mg; amlodipino besilato 10 mg; hidroclorotiazida 25 mg - valsartán, amlodipino e hidroclorotiazida